This page follows insider dealings at Pascal Biosciences Inc. as filed with SEDI. No insider at Pascal Biosciences Inc. has published a filing in the past twelve months. The most recent one dates from 14 June 2021.
Our records for Pascal Biosciences Inc. go back to 2017, with 5 purchases and no sales on the open market in total.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
11 of 11 declarations
Pascal Biosciences Inc. is a biotechnology company focused on developing innovative treatments for cancer and other diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.